AstraZeneca has reported positive full results from its phase 3 NATRON trial evaluating Fasenra (benralizumab) for the ...
Amgen has reported positive results from its phase 3 VESALIUS-CV trial, which demonstrated that Repatha (evolocumab) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback